John C. Aplin serves as Executive at ENDOCYTE INC, where they oversee executive responsibilities. Since joining the company, John C. Aplin has executed 9 insider transactions totaling $65.4K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 21, 2018 involved selling 3,300 shares valued at $79.2K.
John C. Aplin currently holds 32,163 shares of ENDOCYTE INC (ECYT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John C. Aplin has been a net buyer of ECYT stock. They have purchased $65.4K and sold $0 worth of shares.
John C. Aplin's most recent insider trade was on Dec 21, 2018, when they sold 3,300 shares at $24.00 per share.
Get notified when new Form 4 filings are submitted
| 28,863 |
| $24.00 |
| Discretionary |
| May 3, 2018 | ECYT | $0 | Award | 3,300 | $N/A | Discretionary |
| May 4, 2017 | ECYT | $0 | Award | 3,300 | $N/A | Discretionary |
| May 5, 2016 | ECYT | $0 | Award | 2,250 | $N/A | Discretionary |
| May 14, 2015 | ECYT | $0 | Award | 2,250 | $N/A | Discretionary |
| Dec 16, 2011 | ECYT | $65.4K | Purchase | 20,000 | $3.27 | Discretionary |
| Feb 9, 2011 | ECYT | $0 | Conversion | 143,895 | $N/A | Discretionary |
| Feb 9, 2011 | ECYT | $0 | Conversion | 288,235 | $N/A | Discretionary |